Venky’s (India) Ltd Q2 FY26 – Chicken ke Bina Investor ka Kya Kaam? When ₹801 Cr Sales Meet ₹-26 Cr Loss, and the Soya Plant Still Smells Like Trouble
1. At a Glance
Venky’s (India) Ltd, the poultry prince that once promised to make every Sunday “Chicken Day,” just reported a Q2 FY26 performance that feels more like “Fried Investors Day.” The company clocked ₹801 crore in revenue but ended with a net loss of ₹26.5 crore, a brutal -442% swing compared to last year’s ₹8 crore profit. Market cap currently pecks at ₹1,962 crore, with the stock trading around ₹1,392, down nearly 20% in a year.
The stock’s P/E ratio of 85.4 screams “premium,” but the return on equity (8.2%) whispers “thoda sambhal ke.” With sales growth crawling at 0.28% in five years and a profit crash of 79% YoY, Venky’s looks like it’s having more trouble than a chicken stuck in a vegan festival.
Operating margins are gasping at 1.38%, and debt-to-equity remains low at 0.13, proving the balance sheet’s fine—it’s the P&L that’s undercooked.
So, can Venky’s regain its former juicy flavour, or will it remain a dry, unseasoned bite in the FMCG buffet? Let’s cut it open, leg by leg.
2. Introduction – From Chicken Empire to Financial Broiler Farm
Once hailed as the monarch of the Indian poultry market, Venky’s (India) Ltd, a proud member of the VH Group, has been around long enough to serve both your childhood biryani and your midlife portfolio anxiety. The company, best known for its poultry breeding, processed chicken, and animal health products, has had a rollercoaster decade — sometimes spicy, sometimes burnt.
The Pune-based giant isn’t just a chicken farm; it’s a vertically integrated food and animal health ecosystem. From day-old chicks to ready-to-eat kebabs, from feed to pharmaceuticals — Venky’s does it all. They’ve even got a side hustle in soya processing, because why not mix tofu with tandoori?
Yet, despite being a household name (and a household smell), the company’s financial feathers look ruffled. Sales have plateaued, profits have plummeted, and market returns look like they came straight out of a bear’s kitchen. The brand’s glory days of strong demand from KFC, McDonald’s, and Pizza Hut now meet an era where vegan startups are funded faster than Venky’s can hatch a chick.
If FY24 was the “meh” year, FY25 and FY26 are turning out to be the “bhai, yeh kya ho raha hai?” years. Still, with a Rs.70 crore expansion in SPF eggs and a new ₹16 crore ready-to-cook spices line, the bird isn’t fully cooked yet.
3. Business Model – WTF Do They Even Do?
Venky’s business is like a thali – three major items, each fighting for the investor’s attention.
1️ Poultry & Poultry Products – The core of the business, accounting for roughly 35% of FY24 revenues. This includes breeding, hatching, and selling everything from day-old chicks to SPF (Specific Pathogen-Free) eggs. SPF eggs are essential for vaccine manufacturing – a niche where Venky’s is one of Asia’s largest producers.
2️ Animal Health Products (AHP) – Think of this as Venky’s pharmacy for chickens. They manufacture veterinary medicines, feed supplements, and have recently launched a new plant at Kesurdi, Satara, producing 600 tonnes of powders and 300 kilolitres of liquids annually.
3️ Oilseed Segment – This one processes soya, with three plants in Maharashtra having a combined 5.4 lakh MTPA capacity. Soya is not just feed for birds—it’s also a hedge against the volatility of poultry margins. But when both chickens and soy prices swing, the hedge becomes more of a hammock.
They also have a B2C angle—selling packaged, processed, and ready-to-eat meat products. The menu ranges from raw cuts (drumsticks, wings, keema) to breaded items (nuggets, popcorn) and even fully cooked meals like Butter Chicken and Mom’s Chicken Biryani (a product line that ironically didn’t save their quarterly P&L).
Venky’s also supplies chicken to big QSRs like KFC, Pizza Hut, Burger King, McDonald’s, and retail giants like Walmart and Star Bazaar. Essentially, if you’ve eaten chicken in India, you’ve probably eaten Venky’s—congratulations, you’re a stakeholder in spirit.
4. Financials Overview
Metric (₹ Cr)
Latest Qtr (Sep’25)
YoY Qtr (Sep’24)
Prev Qtr (Jun’25)
YoY %
QoQ %
Revenue
801
774
866
+3.4%
-7.5%
EBITDA
-31
14
24
-321%
-229%
PAT
-26.5
8
16
-442%
-265%
EPS (₹)
-18.8
5.5
11.2
-442%
-268%
EBITDA margins fell off the cliff like an overfed rooster, and PAT followed with wings of despair.
Venky’s has turned quarterly profits into a “seasonal product” — available only during festive demand. Q2 FY26 was a loss-fest, showing that even though volumes held steady, input costs (especially feed and energy) singed the profits.
5. Valuation Discussion – Fair Value Range Only
Let’s keep this educational (and non-actionable, obviously):
Method 1 – P/E Approach
Current EPS (TTM): ₹16.3
Industry Average P/E: ~20
Venky’s Current P/E: 85.4 (lol)
Fair P/E Band: 18–25 👉 Fair Value Range = ₹16.3 × (18–25) = ₹293 – ₹408
Method 2 – EV/EBITDA Approach
EV/EBITDA currently = 21
Sector average ~10–12
EBITDA (TTM) = ₹92 Cr (approx.) 👉 Adjusted EV fair = 92 × (10–12) = ₹920 – ₹1,100 Cr With debt ₹181 Cr and market cap ₹1,962 Cr → fair equity value ≈ ₹1,000 – ₹1,200 Cr → Fair value ₹700–₹850/share
Method 3 – DCF (Conservative)
Assume FCF ₹30 Cr growing 8% for 5 years, 3% terminal
